Taro
Welcome,         Profile    Billing    Logout  
 1 Trial 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Yantovskiy, Natalie
NCT06063473: A Study Comparing Trifarotene Cream 0.005% to AKLIEF® Cream in the Treatment of Acne Vulgaris

Completed
1
762
US
Trifarotene Cream 0.005%, Test Product, Placebo, Vehicle, AKLIEF® Cream (Trifarotene 0.005%, Galderma Laboratories), Reference Product
Taro Pharmaceuticals USA
Acne Vulgaris
07/23
07/23
NCT06305637: A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicolor.

Completed
1
430
US
Ketoconazole Shampoo, 2%, Test Product, Ketoconazole Shampoo, 2% (Reference Standard), Reference Product, Placebo, Vehicle
Taro Pharmaceuticals USA
Tinea Versicolor
02/24
02/24
NCT06673641: A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris.

Completed
1
382
US
Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2%, Test Product, CABTREO Topical Gel, Reference Product, Placebo Control, Vehicle
Taro Pharmaceuticals USA
Acne Vulgaris
09/24
09/24
NCT06733402: A Study Comparing Trifarotene Cream 0.005% to AKLIEF® CREAM (US REFERENCE LISTED DRUG), AKLIEF™ CREAM (CANADIAN REFERENCE PRODUCT) in the Treatment of Acne Vulgaris

Completed
1
1000
US
Trifarotene Cream 0.005%, Test Product, AKLIEF® Cream (Trifarotene 0.005%) US REFERENCE LISTED DRUG, Reference Product, AKLIEF® Cream (Trifarotene 50 mcg/g) CANADIAN REFERENCE PRODUCT, Placebo, Vehicle
Taro Pharmaceuticals USA
Acne Vulgaris
06/24
11/24

Download Options